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Abstract
Background: Although the relationship between manifest chronic kidney disease and reduced cognitive function is well
established, limited data exists on GFR and cognitive function in the general population. Both the brain and kidneys have
low-impedance vascular beds, rendering them susceptible to damage from pulsatile blood flow. An association between
mildly reduced GFR and cognitive function in the healthy general population may reveal early disease mechanisms
underlying low-grade impairment of both organs as well as the possibility for intervention. Our aim was to identify an
early stage of low-grade impairments in both the brain and the kidneys in the general population.
Methods: This investigation was a population-based cross-sectional study that included 1627 participants aged 50–62
years who were representative of the general population in the municipality of Tromsø, Norway. The associations
between GFR, measured as iohexol clearance, the urinary albumin-creatinine ratio and performance on five tests of
cognitive function—the Digit Symbol Substitution Test, the finger tapping test, the Mini-Mental State Examination and
the 12-word test parts 1 and 2 – were examined. The data were adjusted for factors known to be associated with both
GFR and cognitive function, including cardiovascular risk factors, medications and education level.
Results: In multivariate adjusted linear regression analyses, we did not observe associations of the measured GFR or
albumin-creatinine ratio with performance on any of the five cognitive tests. In an analysis without adjustment for the
education level, an association of worse performance on the Digit Symbol Substitution Test with higher measured GFR
(p = 0.03) was observed. An exploratory analysis revealed an inverse relationship between mGFR and a higher
education level that remained significant after adjusting for factors known to influence mGFR.
Conclusions: We did not find evidence of an association between low-grade impairments in either the kidneys
or the brain in the middle-aged general population. A possible association between a high GFR and reduced
cognitive function should be investigated in future studies.
Keywords: Middle-aged general population, Measured glomerular filtration rate, Albumin creatinine ratio,
Cognitive function, Cardiovascular risk factors
Background
End-stage renal disease and dementia are important
public health problems that significantly reduce both the
quality and length of life [1, 2]. The prevalence of both
conditions increases with age, contributing to rising
healthcare costs. Preventive measures potentially have a
large impact on health in older aged individuals but
must target the earliest detectable stages of these condi-
tions to be effective [3, 4].
The kidneys and brain share some physiological features
that may render them susceptible to similar pathological
processes. In particular, they both have low-impedance
vascular beds that may be affected by high blood pressure
and increased pulsatile flow, causing tissue injury. A clear
association between overt kidney failure and dementia has
been reported [5], and evidence of an association between
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early stages of cognitive impairment and chronic kidney
disease (CKD) has been presented [5–12].
However, limited data are available on GFR and cogni-
tive function in the general population [5, 11, 13–16].
An association between variations in GFR and reduced
cognitive function in the healthy general population may
indicate the existence of a very early disease stage with
common pathophysiological mechanisms underlying the
dysfunction in both organs. This finding would represent
an opportunity to develop preventive interventions.
However, few studies of cognitive function and GFR
have been conducted in the normal population, and their
results are conflicting [5, 11, 15, 16], possibly because
they all assessed kidney function by estimating GFR
from serum creatinine levels. This methodology may
have biased the results, because GFR estimates are im-
precise for GFR values in the normal range, and creatin-
ine is influenced by non-GFR determinants that are also
associated with vascular disease [17–20].
In the present study, we investigated the association
between measured GFR (mGFR) and reduced perform-
ance on cognitive tests in healthy persons. We also in-
vestigated the same relationships with albuminuria as an
additional measure of kidney dysfunction. Our aim was
to identify an early stage of low-grade impairments in
both the brain and the kidneys in the general population.
We used a cross-sectional design to analyze data from
the Renal Iohexol Clearance Survey in Tromsø 6
(RENIS-T6) and concurrent results of cognitive tests
from the sixth wave of the Tromsø Study.
Methods
Study population
The present study is based on the RENIS-T6 [21, 22].
RENIS-T6 was a sub-study of the sixth survey of the
Tromsø Study (T6), which was performed from October
2007 to June 2009. The Tromsø Study is a series of
population-based surveys in the municipality of Tromsø,
North Norway. In this investigation, data from
RENIS-T6 were coupled with results of cognitive testing
conducted during the main part of the T6.
The sixth survey of the Tromsø Study was conducted
in 2007 and 2008, with a total of 12,984 women and
men participating. All individuals aged 60–62 and a ran-
dom sample of 40% of all individuals aged 50–59 living
in the municipality of Tromsø (n = 5464) were invited to
participate, and 3564 completed the T6. Details on the
Tromsø study has been published previously [21]. Partic-
ipants with self-reported myocardial infarction, angina
pectoris, stroke, diabetes mellitus or renal disease (n =
739) were excluded. The remaining 2825 participants
were invited to participate in the RENIS-T6, and 2107
agreed. Forty-eight did not attend their appointments,
12 were excluded because of allergies to either iodine,
latex or contrast media, and 65 were excluded for other
reasons. The remaining 1982 participants were eligible for
inclusion, and 1632 were investigated according to a
predetermined target. Due to technical failures of the
iohexol-clearance measurements, five additional partici-
pants were excluded, leaving 1627 participants (826 women
and 801 men) in the RENIS cohort (Fig. 1). The cohort has
previously been shown to be representative of the partici-
pants eligible for T6 with regard to key variables [23].
The Data Inspectorate of Norway and the Regional
Committee of Medical and Health Research Ethics of
North Norway approved T6 and RENIS-T6. The study
complied with the Declaration of Helsinki. All subjects
provided written consent.
All investigations in RENIS-T6 occurred at the Clinical
Research Unit of the University Hospital of North Norway.
Iohexol clearance
GFR was measured as iohexol clearance as described in
detail in a previous report [22]. Single-sample iohexol
clearance has been validated against gold-standard
methods [24]. The serum iohexol level was measured
using high-pressure liquid chromatography (HPLC) [25].
External quality control was provided by Equalis (Equalis
AB, Uppsala, Sweden). mGFR was calculated using the
formulas described by Jacobsson [26].
Cognitive function
The cognitive tests included the Digit Symbol Substitu-
tion Test, the finger tapping test, the 12-word test parts
1 and 2, and the Mini-Mental State Examination
(MMSE). Descriptive statistics for the five different cog-
nitive tests are presented in Table 1. Details on these
tests have been published previously [11]. Performance
on the Digit Symbol Substitution Test, the finger tapping
test, the 12-word test parts 1 and 2 is sensitive to early
cognitive changes [11, 27, 28]. The MMSE shows high
sensitivity for detecting moderate-to-severe cognitive
impairments but has lower sensitivity at detecting mild
degrees of impairment [29].
Blood pressure
Ambulatory blood pressure was measured with the
Spacelab 90207 (Spacelab, Redmond, WA). Daytime
mean systolic and diastolic ambulatory blood pressures
were calculated from recordings between 10:00–20:00 h.
Detailed description of these methods have been pub-
lished previously [30].
Other measurements
Albumin and creatinine levels were analyzed in three un-
frozen samples of first-void morning spot-urine collected
on consecutive days using commercial kits [31]. The
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albumin-creatinine ratio (ACR) was calculated for each
sample, and the median was used in the statistical analyses.
All participants completed two self-administered ques-
tionnaires that included questions about smoking and alco-
hol habits. Smoking status was divided into current
smokers or non-smokers, and previous smokers were cate-
gorized as non-smokers. The number of cigarettes currently
smoked was recorded. Alcohol consumption was dichoto-
mized into the consumption of alcohol > 2–4 times a
month (yes/no). Education level 1 indicated primary/sec-
ondary school, modern school, or technical school; level 2
indicated vocational school or 1–2 years senior high school;
level 3 indicated a high school diploma; level 4 indicated
college/university for less than 4 years; and level 5 indicated
college/university for 4 years or more.
Measurements of fasting serum glucose, triglyceride
and high-density and low-density lipoprotein cholesterol
levels were completed with the Modular model P800
(Roche Diagnostics, Indianapolis, IN).
Hemoglobin A1c levels were measured using a liquid
chromatographic method (Variant II instrument,
Bio-Rad Laboratories, Hercules, CA).
Statistical analysis
Continuous variables are presented as means (standard de-
viations (SD)) or medians (interquartile ranges) as appropri-
ate, and categorical variables are presented as numbers of
observations and the percentages of the observations.
ANOVA, median regression, logistic regression and chi
square tests were used as appropriate to examine differ-
ences between the quartiles of mGFR (Table 2).
Separate multiple linear regression models were ana-
lyzed with the Digit Symbol Substitution Test, the finger
tapping test and the 12-word test part 1 as the continu-
ous dependent variables and mGFR as the independent
variable. A median regression analysis was used for per-
formance on the MMSE and the 12-word test part 2, as
these dependent variables yielded non-normal residuals
in the ordinary linear regression analysis (Table 3). For
Fig. 1 Inclusion of participants in the Renal Iohexol Clearance Survey
in Tromsø 6 (RENIS-T6). Refer to the text for details
Table 1 Results and descriptive statistics of the five cognitive tests
The number of observations (%), range of test scores and median scores (interquartile range) on the five different cognitive tests
N (%) Range of possible test score Median (interquartile range) Test domain
The Digit Symbol Substitution testa 1170 (71.9) 0 to 96 possible symbols decoded 45 (38 to 53) Executive function
The finger tapping testb 1137 (69.9) 0 to 70 taps per 10 s 55 (48.6 to 60.3) Motor speed
MMSEc 966 (59.4) 0 to 30 points, where 30 is best 29 (28 to 29) Cognitive function
The 12 word test pt 1d 1178 (72.4) 0 to 12 points, where 12 is best 7 (6 to 8) Verbal episodic memory
The 12 word test pt 2e 1174 (72.2) 0 to 24 points, where 24 is best 20 (18 to 22) Verbal episodic memory
aIn the Digit Symbol Substitution Test, participants are asked to fill in as many correct symbols as possible in 90 s
bIn the finger tapping test, participants are asked to tap with their index finger on the keyboard as fast as possible in 10 s and to repeat this process four times
with each hand
cMMSE indicating Mini-Mental State Examination. In the MMSE, a global cognitive function test, participants are asked to answer several questions and complete
different tasks
d,ePart 1 and 2 of the 12-word test are tests of immediate and cued recall of words
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each of the cognitive tests, adjustments for independent
variables known to be associated with the results of the
tests or mGFR were entered stepwise in a series of
nested models. Models were adjusted for age and gender
(model 1). Model 2 included the adjustments in model 1
as well as the use of alcohol > 2–4 times a month (yes/
no), number of cigarettes smoked daily, daytime mean
ambulatory systolic and pulse pressures, LDL cholesterol
levels, HDL cholesterol levels, fasting triglyceride levels,
and dichotomous variables for the use of angiotensin II
blockers, diuretics, angiotensin-converting enzyme in-
hibitors, calcium blockers, beta blockers, and other anti-
hypertensive medications. Model 3 used the same
variables as model 2 as well as hemoglobin A1C levels.
Model 4 used the same variables as model 3 and in-
cluded ACR. Model 5 included the same variables as
model 4 and education level. The same analyses used for
mGFR were conducted with ACR. Models 1–3 were the
same as described previously, but model 4 for ACR in-
cluded model 3 plus the education level.
Adjustments for multiple comparisons of the five cogni-
tive variables were performed with a Bonferroni correction
to the nominal alpha of 0.05. Accordingly, statistical sig-
nificance was set to p < 0.01 for these analyses. Statistical
significance was set to p < 0.05 for other analyses.
Non-linear effects of mGFR were tested in generalized
additive models for complete cases with the gam proced-
ure in R version 3.2.2 (R Core Team (2013). R: A lan-
guage and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria.
URL http://www.R-project.org/).
Some data for the five different cognitive tests were
missing. The percentages of missing data were 28.1%,
30.1%, 27.6%, 27.8% and 40.6% for the Digit Symbol Sub-
stitution Test, the finger tapping test, 12-word test parts 1
and 2 and the MMSE, respectively. Missing data were ad-
dressed with multiple imputations. Multiple imputations
were performed with STATA/MP (StataCorp LP, College
Station, TX, www.stata.com). The imputation model has
been described in detail in a previous publication [32]. In
the present investigation, the cognitive test variables were
added to the imputation model and imputed using a mul-
tiple linear regression or predictive mean matching ana-
lysis. All statistical tests, except for the analyses of
generalized additive models and the descriptive statistics
presented in Table 2, were performed on 50 imputed data
sets using the command mi estimate in Stata.
Results
The performance of the total cohort on the five cogni-
tive tests is presented in Table 1 and the baseline charac-
teristics of participants included in the RENIS-T6 are
presented in Table 2. The mean mGFR (SD) was 92 (14)
ml/min/1.73 m2 and 34 participants had mGFR < 60ml/
min/1.73m2. Significant differences in gender, age,
height, body weight, daily smoking, HDL cholesterol
levels, triglyceride levels, daytime ambulatory systolic
and diastolic blood pressures, pulse pressure and educa-
tion level were observed among the GFR quartiles. The
intercorrelation between the five different cognitive tests
can be found in the Additional file 1: Table S1.
The results from multiple linear regression analyses
with performance on the five different cognitive tests as
the dependent variables and mGFR as the independent
variable are shown in Table 3. A statistically significant
association was observed between a higher mGFR and
worse performance on the Digit Symbol Substitution
Test in model 1 (p = 0.006), with a strong tendency to-
ward an association in Models 2 to 4. The association
was attenuated and not statistically significant when the
education variable was added to Model 5. An explora-
tory analysis of the relationship between mGFR and edu-
cation is presented in the Additional file 1: Table S2.
This analysis identified an inverse relationship between
mGFR and education level in analyses adjusting for fac-
tors known to influence mGFR, such that a longer dur-
ation of education was associated with a lower mGFR (p =
0.001). We did not observe statistically significant associa-
tions between mGFR and performance on the finger
tapping test, the MMSE and the 12-word test parts 1 and
2 among the five different models.
The results from the regression analyses with perform-
ance on the five different cognitive tests as the
dependent variables and ACR as the independent vari-
able are shown in Table 4. Urinary ACR was not statisti-
cally significantly associated with performance on any of
the five cognitive tests in any of the four models.
Interactions between the mGFR and age and between
ACR and age in their associations with cognitive func-
tion were examined. No statistically significant interac-
tions were identified in any of the five models for
performance on the five different cognitive tests.
In the fully adjusted models, statistically significant
non-linear associations were not observed between mGFR
or ACR and performance on any of the five cognitive tests.
Discussion
In the fully adjusted regression analyses, we did not ob-
serve an association of mGFR or ACR with performance
on five different cognitive tests in the healthy
middle-aged general population. Narrow confidence in-
tervals for the beta coefficients in the regression models
argue against any clinically significant associations of
mGFR or ACR with performance on the cognitive tests.
To the best of our knowledge, the association between
cognitive and kidney function in the general population
has not previously been investigated using mGFR. How-
ever, estimated GFR (eGFR) has been used in some
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cross-sectional population-based studies [6, 13, 33, 34].
The third National Health and Nutrition Examination
Survey (NHANES III), the Health, Aging, and Body
Composition study, the Cardiovascular Health Study and
the Maine-Syracuse Longitudinal Study all reported as-
sociations between an eGFR < 60ml/min/1.73 m2, i.e.,
manifest CKD, and reduced performance on cognitive
tests [13, 34–36]. The Maine-Syracuse Longitudinal
Study reported that participants with eGFR < 60ml/min/
1.73m2 had decreased performance within specific do-
mains of cognition compared with participants with
eGFR > 60 ml/min/1.73m2 [34]. They used a battery of
neuropsychological tests organized into theoretically
cognitive domains which is more extensive than the five
different cognitive tests used in our study [34]. An asso-
ciation between eGFR in the normal range and cognitive
function was not observed in the NHANES III [35] and
was not examined in the Health, Aging, and Body
Table 2 Baseline characteristics of the RENIS-T6 participants according to mGFR-quartiles, n = 1627
Quartile of glomerular filtration rate, range (ml/min/1.73 m2)
Quartile 1 Quartile 2 Quartile 3 Quartile 4
(21.9–82.8) (82.8–91.5) (91.5–101.2) (101.2–138.6)
N (%) 407 (25.0) 407 (25.0) 407 (25.0) 406 (25.0)
Female, n (%) 283 (69.5) 221 (54.3) 193 (47.4) 129 (31.8)a
Age, years 59.2 ± 3.5 58.2 ± 3.8 57.6 ± 3.9 57.3 ± 3.9a
Height, cm 169.3 ± 8.6 170.5 ± 8.5 170.8 ± 9.1 172.0 ± 8.6a
Body weight, kg 78.8 ± 14.1 78.9 ± 14.1 79.7 ± 14.6 81.4 ± 14.6b
Body mass index, kg/m2 27.5 ± 4.4 27.1 ± 4.0 27.2 ± 3.7 27.4 ± 3.8
Daily smoking, n (%) 77 (19.0) 71 (17.5) 80 (19.7) 116 (28.6)b
Use of alcohol > 2–4 times a month, n (%) 112 (27.7) 116 (28.6) 99 (24.4) 115 (28.3)
LDL cholesterol, mmol/l 3.64 ± 0.83 3.66 ± 0.87 3.75 ± 0.86 3.63 ± 0.87
HDL cholesterol, mmol/l 1.57 ± 0.43 1.58 ± 0.42 1.52 ± 0.42 1.46 ± 0.40a
Triglycerides, mmol/l 1.1 (0.8 to 1.4) 1.0 (0.7 to 1.3) 1.1 (0.7 to 1.5) 1.1 (0.8 to 1.5)
UACR, mg/mmol 0.23 (0.1 to 0.56) 0.23 (0.1 to 0.52) 0.19 (0.1 to 0.50) 0.28 (0.1 to 0.60)
UACR > =3.4 mg/mmol, n (%) 8 (2.0) 6 (1.5) 6 (1.5) 4 (1.0)
HbA1c % 5.53 ± 0.36 5.54 ± 0.34 5.56 ± 0.34 5.59 ± 0.40
Systolic BP, mmHg 129.3 ± 13.6 129.2 ± 13.6 129.9 ± 12.5 132.3 ± 12.8b
Diastolic BP, mmHg 80.9 ± 9.1 81.9 ± 9.0 82.2 ± 8.4 83.4 ± 8.1a
Pulse pressure, mmHg 74.6 ± 9.5 73.2 ± 10.2 74.3 ± 9.9 75.4 ± 10.1b
Antihypertensive medication, n (%)
Diuretics 46 (11.3) 36 (8.8) 36 (8.8) 29 (7.1)b
Beta blockers 23 (5.7) 17 (4.2) 19 (4.7) 13 (3.2)
Calcium blockers 29 (7.1) 15 (3.7) 22 (5.4) 16 (3.9)
Angiotensin-converting enzyme inhibitor 8 (2.0) 10 (2.5) 2 (0.5) 9 (2.2)
Angiotensin II blockers 38 (9.3) 37 (9.1) 37 (9.1) 27 (6.7)
Other 0 0 0 2 (0.5)
Educationc, n (%)
Level 1 95 (23.3) 98 (24.2) 106 (26.1) 108 (26.9)
Level 2 114 (28.0) 115 (28.1) 123 (30.3) 139 (34.7)
Level 3 30 (7.3) 28 (6.9) 26 (6.4) 31 (7.7)
Level 4 87 (22.4) 66 (17.1) 87 (22.5) 69 (18.1)
Level 5 81 (20.0) 98 (24.2) 64 (15.8) 54 (13.5)
Values are presented as n (%), means ± SD, or medians (interquartile ranges). Abbreviations: RENIS-T6 Renal Iohexol Clearance Survey in Tromsø 6, mGFR
measured glomerular filtration rate, HDL high density lipoproteins, LDL low density lipoprotein, BP blood pressure, UACR urinary albumin creatinine ratio.
ap < 0.001 for linear trends across quartiles
bp < 0.05 for linear trend across quartiles
cEducation level 1 indicated primary/secondary school, modern school, or technical school; level 2 indicated vocational school or 1–2 years senior high school;
level 3 indicated a high school diploma; level 4 indicated college/university for less than 4 years; and level 5 indicated college/university for 4 years or more
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Table 3 Results of the multivariate linear regression analysis using GFR as the independent variable and performances on the
different cognitive tests as the dependent variables
Model 1a Model 2b Model 3c Model 4d Model 5e
β P β P β P β P β P
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
The Digit Symbol Substitution Test −0.65 0.006 −0.57 0.02 − 0.52 0.03 −0.52 0.03 −0.31 0.18
(−1.12 to − 0.19) (−1.03 to − 0.11) (− 0.98 to 0.05) (−0.98 to − 0.05) (− 0.76 to 0.15)
The finger tapping test −0.15 0.38 −0.14 0.43 −0.13 0.48 −0.12 0.49 −0.03 0.86
(−0.52 to 0.20) (−0.50 to 0.21) (−0.48 to 0.23) (−0.48 to 0.23) (0.39 to 0.32)
MMSEf −0.00 1.00 −0.003 0.92 −.004 0.91 −0.004 0.89 −0.003 0.93
(−0.05 to 0.05) (−0.06 to 0.06) (−0.07 to 0.06) (−0.07 to 0.05) (−0.07 to 0.06)
The 12 word test pt 1 −0.05 0.19 −0.04 0.22 −0.04 0.22 −0.04 0.23 −0.02 0.58
(−0.12 to 0.02) (−0.11 to 0.03) (−0.11 to 0.03) (−0.11 to 0.03) (−0.09 to 0.05)
The 12 word test pt 2f −0.02 0.84 −0.12 0.17 −0.14 0.10 −0.14 0.10 −0.13 0.17
(−0.25 to 0.20) (−0.30 to 0.05) (−0.31 to 0.03) (−0.31 to 0.03) (−0.31 to 0.05)
Beta coefficients are presented as an increase in performance on each test per 10 ml/min/1.73 m2 increase in mGFR. MMSE indicating Mini-Mental
State Examination.
aModel 1 was adjusted for age and gender
bModel 2 was adjusted for the same variables as model 1, as well as the consumption of alcohol > 2–4 times per month (yes/no), daily numbers
of cigarettes smoked, daytime ambulatory mean systolic and pulse pressures, LDL cholesterol levels, HDL cholesterols levels, triglyceride levels,
and dichotomous variables for the use of angiotensin II blockers, diuretics, angiotensin-converting enzyme inhibitors, calcium blockers, beta
blockers, and other antihypertensive medications
cModel 3 was adjusted for the same variables as model 2, as well as hemoglobin A1c levels
dModel 4 was adjusted for the same variables as model 3, as well as the urinary ACR
eModel 5 was adjusted for the same variables as model 4, as well as the education level
fA median regression analysis was used for performance on the MMSE and the 12-word test part 2
Table 4 Results of the multivariate linear regression analysis using the urinary ACR as the independent variable and performances
on the different cognitive test as the dependent variables
Model 1a Model 2b Model 3c Model 4d
β P β P β P β P
(95% CI) (95% CI) (95% CI) (95% CI)
The Digit Symbol Substitution Test −0.62 0.63 0.0009 1.0 0.03 0.84 0.02 0.87
(−0.31 to 0.19) (−0.25 to 0.25) (−0.22 to 0.27) (−0.22 to 0.26)
The finger tapping test −0.16 0.11 −0.11 0.25 −0.10 0.28 −0.11 0.26
(−0.35 to 0.03) (−0.30 to 0.08) (−0.29 to 0.08) (−0.29 to 0.08)
MMSEe −0.002 0.93 −0.004 0.85 −0.004 0.84 −0.005 0.81
(−0.036 to 0.03) (−0.04 to 0.04) (−0.05 to 0.04) (−0.05 to 0.04)
The 12 word test pt 1 −0.03 0.09 −0.02 0.22 −0.02 0.22 −0.03 0.12
(−0.07 to 0.005) (−0.06 to 0.01) (−0.05 to 0.01) (−0.06 to 0.009)
The 12 word test pt 2e −0.003 0.96 −0.01 0.79 −0.02 0.71 −0.01 0.76
(−0.13 to 0.12) (−0.11 to 0.08) (−0.11 to 0.08) (−0.11 to 0.08)
Beta coefficients are presented as an increase in performance on each test per 1 mg/mmol increase in urinary ACR. MMSE indicating Mini-Mental
State Examination.
aModel 1 was adjusted for age and gender
bModel 2 was adjusted for the same variables as model 1, as well as the consumption of alcohol > 2–4 times per month (yes/no), daily numbers of cigarettes
smoked, daytime ambulatory mean systolic and pulse pressures, LDL cholesterol levels, HDL cholesterol levels, triglyceride levels, and dichotomous variables for
the use of angiotensin II blockers, diuretics, angiotensin-converting enzyme inhibitors, calcium blockers, beta blockers, and other antihypertensive medications
cModel 3 was adjusted for the same variables as model 2, as well as hemoglobin A1c levels
dModel 4 was adjusted for the same variables as model 3, as well as the education level
eA median regression analysis was used for performance on the MMSE and the 12-word test part 2
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Composition study, the Maine-Syracuse Longitudinal
study or the Cardiovascular Health Study [13, 34, 36].
Consistent with the results of the present study, neither
the Prevention of Renal and Vascular End-Stage Disease
(PREVEND) study nor the Maastricht Study observed as-
sociations between performance on cognitive tests and
eGFR in the general population in the Netherlands [6, 37].
In contrast, both of these studies did report associations
between albuminuria and cognitive dysfunction. However,
in the PREVEND study, the association was present only
in persons younger than 48 years and not in the age group
included in the present study. Also, the PREVEND study
used the Ruff Figural Fluency Test which is supposed to
be more sensitive than the tests included in our study [6].
In the Maastricht Study, only information processing
speed was associated with albuminuria, predominantly in
older individuals [37]. Since we did not test the informa-
tion processing speed and our sample included younger
subjects, the results are not directly comparable.
Longitudinal studies have reported conflicting results.
According to the Baltimore Longitudinal Study of Aging,
longitudinal increases in creatinine concentrations with
increasing age were associated with more rapid decline
in performance on several cognitive measures [33].
However, the calculation of eGFR using creatinine- or
cystatin c-based equations is imprecise, particularly for
GFR values in the normal or near-normal range [17]. In
another study, Wang et al. did not observe an associ-
ation between cognitive decline and mildly decreased
baseline eGFR (60–89ml/min/m2) compared to an eGFR
greater than 90ml/min/m2 after adjusting for albumin-
uria and other risk factors [15]. Davey et al. measured
longitudinal changes in cognitive function on eGFR in a
population without dementia and end-stage-renal dis-
ease. They reported that decline in cognitive function
was associated with decline in renal function [5]. How-
ever, the two specific cognitive domains that declined
longitudinally in association with a decline in the eGFR
were similarities (abstract reasoning) and verbal mem-
ory, and since our tests did not specifically test these do-
mains the results are not directly comparable. Helmer et
al. examined eGFR as a continuous variable across the
whole range of eGFR values in the general population
and did not observe an association between baseline
eGFR and the incidence of dementia [16].
The paradoxical association between increasing mGFR
and worse performance on the Digit Symbol substitution
Test was attenuated when the subjects’ education levels
were added to the model. Both better kidney function
and better education are believed to be associated with
better health, including cognitive function. Previous
studies have treated education as a confounder [5–7, 9,
13, 34–36], implying that education affects both the out-
come of cognitive tests and GFR. An alternative view is
that the test is a measure of cognitive ability, which is
also a partial determinant of education level. Based on
this assumption, education would not be a confounder
and should not be adjusted for in statistical analyses.
Consistent with our findings, Rogne et al. found that a
higher eGFR predicted slightly worse performance on
the Digit Symbol Substitution Test. After adjusting for
education and other confounders, the association was at-
tenuated but still statistically significant [11]. Two other
studies that adjusted for education suggest that the rela-
tionship between GFR and cognitive function may be bi-
phasic, with cognitive dysfunction associated with both a
low (GFR < 60 ml/min/1.73 m2) and high GFR (≥ 90ml/
min/1.73 m2) [37, 38]. However, these studies used eGFR
rather than mGFR. Creatinine-based eGFR may overesti-
mate GFR because of reduced muscle mass. In older pa-
tients, high eGFR may result from reduced muscle mass
rather than hyperfiltration. Nevertheless, according to
other epidemiological evidence, abnormally high GFR
levels in non-diabetic persons may be a risk factor for
disease. Hyperfiltration is associated with prediabetes,
hypertension and other cardiovascular risk factors [39,
40], and it may also confer an increased risk for cardio-
vascular disease [32, 41, 42].
The ACR in our study was also considerably lower
than the ratios observed in studies that reported an
association with cognitive impairment. In a recent
meta-analysis, Georgakis et al. found a clear association
between cognitive impairment and albuminuria, defined
as an ACR greater than 3.4 mg/mmol. However, when
the ACR was analyzed as a continuous variable, the risk
of cognitive impairment or dementia was very low for
ACRs that were slightly higher than values correspond-
ing to the ACRs observed in the present study (odds ra-
tio of approximately 1.03 for ACR 0.5 to 1.0 mg/mmol)
[12]. Our study may have had insufficient power to de-
tect an even smaller effect.
Although the association between manifest CKD and
cognitive dysfunction is well established, this study did
not identify an early stage of impairment in both the brain
and the kidneys. Our study population comprised
middle-aged participants with normal or only low-grade
impairments in both organs. Although an age-related de-
crease in GFR was identified in most participants, the cog-
nitive changes may have been too small to be detected.
The five different cognitive tests are thoroughly validated,
but we cannot exclude the possibility that their sensitivity
was too low to detect early stages of cognitive deficit.
However, when testing for interactions of age with mGFR
and ACR, we did not find evidence that increasing age
changed the association with performance on the cogni-
tive tests. Despite the similarities between the vascular
beds of the two organs, one possible implication of this
negative finding is that the pathophysiological processes
Småbrekke et al. BMC Nephrology          (2019) 20:166 Page 7 of 9
behind age-related changes in the kidney are distinct from
those responsible for cognitive impairment. This hypothesis
may also partially explain the positive findings in popula-
tions where prevalent comorbidity may affect both organs.
Because we identified a relationship between mGFR,
performance on cognitive tests and education, we per-
formed a hypothesis-generating investigation of the asso-
ciation between mGFR and education (Additional file 1:
Table S2). A highly statistically significant inverse rela-
tionship between mGFR and education was observed,
such that the highest level of education was associated
with a 4 ml/min/1.73 m2 lower mGFR (p = 0.001) after
adjusting for several possible confounders. This finding
was unexpected but may be explained by a lower preva-
lence of renal hyperfiltration with increasing education
level. This result must be interpreted with caution, as
the analysis was not specified in our original project
protocol.
The most important strength of this study is the use of
mGFR instead of eGFR, and the use of three urine samples
for measuring median ACR. However, we were unable to
study the effect of ethnicity because our study population
included only Caucasians. The cross-sectional design limits
any causal inferences, but our aim was to identify a state
with low-grade dysfunction of both the brain and the kid-
neys rather than to study causal relationships.
Conclusion
We did not observe associations of mGFR or ACR with
performance on the five different cognitive tests in
healthy participants aged 50–62 years who were repre-
sentative of the general population. The association be-
tween education, GFR and cognitive function should be
investigated in future longitudinal studies.
Additional files
Additional file 1: Table S1. Intercorrelation between the five different
cognitive tests. Table S2. An exploratory analysis of the relationship
between mGFR and education. (DOCX 17 kb)
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